We provide full life-cycle representation for emerging companies in the life science, biotechnology, computer software, information technology, construction services, health care, and financial and professional services industries.

We work closely with our clients to create principled corporate governance and commercial transactional strategies for developing and bringing products to market.  We also assist our clients in structuring, negotiating, and completing financing, teaming, joint venture and M&A transactions intended to accelerate growth or provide liquidity to entrepreneurs and investors.  Our lawyers have significant expertise in negotiating and drafting strategic and transactional IP licensing, technology development, and technology marketing agreements and have completed venture capital transactions in the biotechnology, life sciences and IT sectors.

Representative Matters- Information Technology and Computer Software

  • Licensing counsel to industry-leading data translation software company
  • Transaction counsel to SaaS firm providing ERP reporting tools and workforce analytics solutions to Fortune 1000 companies
  • Lead counsel in commercial software licensing transactions with major Blue Cross/Blue Shield affiliates
  • Representing IT products and services firm on software licensing, systems integration, and application development matters
  • Counsel to leading eCommerce products and services firm on strategic partnerships, services engagements and software product development issues
  • Representing leading IT firm on transactional and partnering matters
  •   Corporate counsel to market-leading health care IT products and services firm
  • Corporate counsel to market-leading media software firm
  • Representing enhanced RF products and services company on licensing, reselling, and general transactional matters
  • Negotiating software product development agreements for supply chain management, property management, and medical practice management product vendors
  • Counsel to IT outsourcing and resource placement firm

Representative Matters – Life Sciences and Biotechnology

  • Advising emerging biotechnology and life sciences firms on acquisition of more than $100MM in early-stage and expansion equity financing
  • Counsel to early-stage life sciences venture capital fund on placement of $40MM in investment
  • General Counsel to venture-backed cancer diagnostic company
  • Negotiation of collaborative research agreements between emerging biotechnology companies and multinational life sciences firms
  • Advising clients on clinical research and investigation agreements to support late-stage clinical trials